Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2025-10-09 00:00:00 ET · period of report 2025-10-07 · accession 0001578852-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-09 | 2025-10-07 | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $63.43 | -3,375 | 104.2K | -3% | -$214.1K |
| D | 2025-10-09 | 2025-10-07 | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $38.10 | +3,375 | 107.3K | +3% | +$128.6K |
| D | 2025-10-09 | 2025-10-07 | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $0.00 | -3,375 | 3,376 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-07 | S | D | 1,757 | $62.89 | 105,519 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $62.36 to $63.28 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-10-07 | M | A | 3,375 | $38.10 | 107,276 | D | — | — | |
| 3 | Common | Common Stock | 2025-10-07 | S | D | 312 | $64.97 | 103,901 | D | — | — | (F4) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.56 to $65.01 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-10-07 | S | D | 1,306 | $63.80 | 104,213 | D | — | — | (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $63.36 to $64.25 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-10-07 | M | D | 3,375 | $0.00 | 3,376 | D | $38.10 · — to 2032-01-06 | 3,375 Common Stock | (F5) This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023. |